• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL MACCONKEY II AGAR; CULTURE MEDIA, SELECTIVE AND DIFFERENTIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL MACCONKEY II AGAR; CULTURE MEDIA, SELECTIVE AND DIFFERENTIAL Back to Search Results
Model Number 221270
Medical Device Problem Code Contamination of Device Ingredient or Reagent (2901)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/07/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported when using the media, bd bbl macconkey ii agar, biological contamination was observed.There was no report of adverse patient impact.The following information was provided by the initial reporter: "it was reported by the customer that found about 80 plates that were contaminated.".
 
Additional Manufacturer Narrative
H.6 investigation summary during manufacturing of material 221270, media is formulated and sent through a high temperature short time sterilizer to remove bioburden.The petri dishes are subjected to uv radiation to decrease bioburden.The petri dishes are filled in a positive pressure hepa filtered environment.The filled plates are cooled and immediately wrapped into sleeves to decrease the introduction of microbes.Sleeves are then packaged into cartons and then transferred to a refrigerated truck (2 to 8 degrees c) for shipment to the distributor.Bd distributors are provided with the storage guidelines for the shipping and handling of bd media of 2 to 8 degrees c in a dark place.The batch history record was revied for batch 2109300 was satisfactory and no quality notifications were generated during manufacturing and inspection.The release testing that is performed on this product does include bioburden testing.A sample of plates are incubated at 25 degrees c and at 35 degrees c for approximately 72 hours.All bioburden testing performed on this batch was satisfactory per bd internal procedures.Affected product does not have any sterility claims; the product is tested for bioburden prior to release to ensure that it conforms to product specifications.However, this does not ensure that the end-user will not receive a contaminated plate.The complaint history was reviewed, and one other complaint has been taken on batch 2109300 for contamination.Retention samples from batch 2109300 were not available for investigation.Four photos were received.Photo one (lot 2109300 timestamp 1480) shows one plate with a large red colony and a smaller seeming colony visible on the plate.Photo two shows one plate (lot unreadable timestamp 0041) with many red colonies visible on the agar surface of the plate.Photo three shows a sleeve from lot 2109300.Photo four show one plate (lot 2109300 timestamp 1480) with four colonies on the plate.The complaint can be confirmed.The batch number in the photos show the contamination on the surface of the plate.No complaint trends for this defect have been identified for this product; no actions are indicated at this time.Bd will continue to trend complaints for contamination.H3 other text : see h.10.
 
Event or Problem Description
It was reported when using the media, bd bbl macconkey ii agar, biological contamination was observed.There was no report of adverse patient impact.The following information was provided by the initial reporter: "it was reported by the customer that found about 80 plates that were contaminated.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL MACCONKEY II AGAR
Common Device Name
CULTURE MEDIA, SELECTIVE AND DIFFERENTIAL
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key14939051
Report Number1119779-2022-00959
Device Sequence Number4995154
Product Code JSI
UDI-Device Identifier10382902212703
UDI-Public10382902212703
Combination Product (Y/N)N
Initial Reporter StateNC
Initial Reporter CountryUS
PMA/510(K) Number
EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date07/20/2022
Device Model Number221270
Device Catalogue Number221270
Device Lot Number2109300
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/07/2022
Supplement Date Received by Manufacturer01/20/2023
Initial Report FDA Received Date07/06/2022
Supplement Report FDA Received Date01/24/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured04/19/2022
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-